Delivery Order SPE2DE21D0017-SPE2D626F6022
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on October 23, 2025, valued at $2,400 for Alere ID NOW Flu A/B Qualification Detection Virus kits. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and is set to be completed by October 29, 2025. The funding agency is the Defense Logistics Agency Medical Supply Chain, a defense-affiliated entity responsible for sourcing medical supplies and...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,800.00 on September 23, 2025, for the supply of Alere ID NOW Flu A and B2 Qualified Detector Virus kits. The contract is a fixed-price delivery order with economic price adjustment provisions and will be performed in Lockhart, Florida, with an ultimate completion date of September 30, 2025. The award was made without a set-aside designation, indicating open competition. The...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a $1,200 fixed-price delivery order with economic price adjustment from the Defense Logistics Agency Medical Supply Chain on April 28, 2025, for ID NOW flu diagnostic tests. The contract, awarded without set-aside designation through open competition, is designated as delivery order 4568059894 and carries an ultimate completion date of May 5, 2025. Performance will be executed at the contractor's location in...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $15,000 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency (DLA) Medical Supply Chain on August 7, 2025, for ID NOW flu diagnostic testing products. The contract, which carries no set-aside designation, indicates open competition and is scheduled for ultimate completion on August 14, 2025. Performance will occur at the vendor's location in Lockhart, Florida. This...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a fixed-price delivery order valued at $69,600 by the Defense Logistics Agency's Medical Supply Chain on August 21, 2025. The contract, which runs through August 28, 2025, covers ID NOW flu testing supplies and is classified as a Delivery Order with economic price adjustment provisions. The award was made through open competition with no set-aside designation, and performance will occur in Lockhart, Florida....
- This is a federal contract award from the Defense Logistics Agency (DLA) Medical Supply Chain to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The $2,208.00 fixed-price with economic price adjustment delivery order is for the ID NOW FLU product, which is a medical diagnostic testing device. The contract has an ultimate completion date of May 2, 2025 and was awarded on April 25, 2025. This award is not associated with a set-aside designation. Abbott Rapid DX North...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $3,624.00 fixed-price delivery order with economic price adjustment on September 18, 2025, for an ID NOW point-of-care clinical analyzer. The contract is scheduled for completion by September 22, 2025, and will be performed in Lockhart, Florida. The award was made without a set-aside designation, indicating open competition. Funding is provided by the Defense Logistics Agency Medical Supply Chain, a...
- This federal contract award, with ID SPE2DE21D0017|SPE2D624F6X4T, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The $43,200.00 fixed-price with economic price adjustment delivery order is for the supply of 4564728806 ID NOW FLU diagnostic products, without any set-aside designation. Abbott Rapid DX North America LLC, doing business as Alere North America LLC, is a major supplier...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $2,400.00 delivery order by the Defense Logistics Agency Medical Supply Chain on October 23, 2025, for COVID-19 virus test kits (KIT ID NOW COVID-19 VIR TST 24 TST). The contract utilizes fixed-price pricing with economic price adjustment provisions and is scheduled for completion by October 31, 2025. Performance will be conducted at the company's location in Lockhart, Florida. This delivery order was...
- This federal contract award, valued at $5,472.00, was issued by the Defense Logistics Agency Troop Support Medical division to Abbott Rapid DX North America LLC, doing business as Alere North America LLC. The award is a delivery order contract for the provision of medical diagnostic equipment and supplies, specifically 4566554944 ! ID NOW FLU kits. This award does not have a set-aside designation. Abbott Rapid DX North America LLC is a subsidiary of the larger parent company, Abbott Laboratories...
- SPE2DE21D0017Indefinite Delivery Contract
- SPE2DE21D0017-SPE2D626F6022Delivery Order
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a $5,616.00 delivery order award on October 28, 2025, for the procurement of Alere ID NOW Flu A/B2 Qualified Detect Virus kits. The contract is a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of November 4, 2025. Funding originates from the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for procuring medical supplies and equipment for Department of Defense operations. The place of performance is Lockhart, Florida, where Abbott maintains its principal operations for diagnostic testing products. No small business set-aside was used in this award, indicating it was issued on a full and open competitive basis. This delivery order represents a continuation of Abbott's established role as a critical supplier of rapid diagnostic testing solutions to federal healthcare agencies. The ID NOW platform serves as a molecular diagnostic system capable of detecting multiple respiratory pathogens, including influenza A and B viruses, and aligns with the Department of Defense's medical readiness requirements for point-of-care testing capabilities. Abbott has demonstrated sustained performance across extensive federal procurement portfolios, including numerous contracts with the Defense Logistics Agency, Department of Veterans Affairs, and Defense Health Agency, positioning the company as a primary vendor for diagnostic testing supplies and equipment within federal healthcare procurement channels.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 10/28/25 |